Pricing Log in Create free account

Canton Strategic Holdings, Inc. (CNTN) vs Oramed Pharmaceuticals Inc. (ORMP)

Canton Strategic Holdings, Inc. and Oramed Pharmaceuticals Inc. are both Biotechnology companies. Canton Strategic Holdings, Inc. and Oramed Pharmaceuticals Inc. are of similar size ($172.1M and $171.8M). Canton Strategic Holdings, Inc. has negative trailing earnings, so its P/E is not meaningful; Oramed Pharmaceuticals Inc. trades at 0.9×. Across the 9 metrics below, Oramed Pharmaceuticals Inc. leads on 7 and Canton Strategic Holdings, Inc. on 2.

Valuation

Metric CNTN ORMP Biotechnology median
P/E n/m 0.93 10.26
P/S n/m 40.01 9.18
P/B 0.92 0.51 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales n/m 27.42 8.98
Earnings yield (47.53%) 107.91% (34.89%)
Free cash flow yield (5.32%) (3.24%) (24.52%)

Profitability

Metric CNTN ORMP Biotechnology median
Gross margin — 32.31% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (43.10%) 73.90% (50.12%)
Return on assets (34.60%) 65.52% (45.60%)
Return on invested capital (8.11%) (3.40%) 0.00%

Growth

Metric CNTN ORMP Biotechnology median
Revenue growth (TTM) — 48.76% 6.26%
EPS growth (last fiscal year) 88.10% 412.50% 29.88%
Revenue growth, 5-year CAGR — (5.85%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CNTN ORMP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 15.70 4.98 4.89
Net debt to EBITDA 0.85 8.41 1.01

Dividend

Metric CNTN ORMP Biotechnology median
Dividend yield — 6.38% 0.41%
Payout ratio — 0.06 —

Size

Metric CNTN ORMP Biotechnology median
Market cap 172.11m 171.80m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack